Details of the Drug-Related molecule(s) Interaction Atlas

Unii-I92MU0V408 Drug Info

UNII-I92MU0V408; I92MU0V408; SCHEMBL1695326; CHEMBL3695568; RTDCVLCTBQDLBW-UHFFFAOYSA-N; BDBM142597; RV568; US8933228, Ref 1; RV-568; JNJ-49095397; N-(4-(((4-((((3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl)amino)carbonyl)amino)-1-naphthalenyl)oxy)methyl)-2-pyridinyl)-2-methoxyacetamide; Acetamide, N-(4-(((4-((((3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl)amino)carbonyl)amino)-1-naphthalenyl)oxy)methyl)-2-pyridinyl)-2-methoxy-; 1220626-82-3; N-[4-({4-[3-(3-tert-Butyl-1-p-tolyl-1H-pyrazol-5-yl)ur

Cross-matching ID

PubChem CID

45109868

CAS Number

CAS 1220626-82-3

TTD Drug ID

DMUD7H8

General Information of Drug (ID: DMUD7H8)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Hematopoietic cell kinase (HCK)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
BK3	DM6YQO3	N. A.	N. A.	Patented	[2]
Doramapimod	DM6BU7N	Inflammatory bowel disease	DD72	Patented	[1]
3-(6-allyloxy-2-naphthyl)-1-(4-piperidylmethyl)pyrazolo[3,4-d]pyrimidin-4-amine	DM0DYAU	N. A.	N. A.	Patented	[2]
US8933228, 3	DMPNCOL	N. A.	N. A.	Patented	[1]
SB19065	DM2MQD0	N. A.	N. A.	Patented	[3]
US9108950, 1	DMPT2ZS	N. A.	N. A.	Patented	[4]
US8933228, Ref 2	DMKEX51	N. A.	N. A.	Patented	[5]
BK7	DMQD4X2	N. A.	N. A.	Patented	[2]
PP121	DMU8KTO	Discovery agent	N.A.	Investigative	[6]
PMID15546730C2	DMOPUIH	Discovery agent	N.A.	Investigative	[7]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Hematopoietic cell kinase (HCK)	TT42OGM	HCK_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Respiratory formulations and compounds for use therein. US8933228.
2	Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases. US9765037.
3	Anti-inflammatory compound having inhibitory activity against multiple tyrosine kinases and pharmaceutical composition containing same. US9062066.
4	1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as p38 MAP kinase inhibitors. US9108950.
5	1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as P38 MAP knase inhibitors. US9724347.
6	Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases. Nat Chem Biol. 2008 Nov;4(11):691-9.
7	Discovery of novel 2-(aminoheteroaryl)-thiazole-5-carboxamides as potent and orally active Src-family kinase p56(Lck) inhibitors. Bioorg Med Chem Lett. 2004 Dec 20;14(24):6061-6.